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Abstract
For many years the lung has been considered off-limits for ultrasound. However, it has been recently shown that
lung ultrasound (LUS) may represent a useful tool for the evaluation of many pulmonary conditions in
cardiovascular disease. The main application of LUS for the cardiologist is the assessment of B-lines. B-lines are
reverberation artifacts, originating from water-thickened pulmonary interlobular septa. Multiple B-lines are present
in pulmonary congestion, and may help in the detection, semiquantification and monitoring of extravascular lung
water, in the differential diagnosis of dyspnea, and in the prognostic stratification of chronic heart failure and acute
coronary syndromes.
Background
Sonographic prejudices: the history of lung ultrasound
For many years ultrasound has not been employed for
the evaluation of the lung [1]. All diagnostic ultrasound
methods are based on the principle that ultrasound is
reflected by an interface between media with different
acoustic impedance. In normal conditions, with aerated
lungs, the ultrasound beam finds the lung air and no
image is visible, because no acoustic mismatch may
reflect the beam, which is rapidly dissipated by air [2].
The only detectable structure is the pleura, visualized as
a hyperechoic horizontal line, moving synchronously
with respiration (see additional file 1). When the air
content decreases - as in pulmonary edema, pulmonary
fibrosis, etc. - the acoustic mismatch needed to reflect
the ultrasound beam is created, and some images
appear. In the presence of extravascular lung water
(EVLW), the ultrasound beam finds subpleural interlob-
ular septa thickened by edema. The reflection of the
beam creates some comet-tail reverberation artifacts,
called B-lines or ultrasound lung comets. A B-line is a
discrete, laser-like, vertical, hyperechoic image, that
arises from the pleural line, extends to the bottom of
the screen without fading, and moves synchronously
with respiration. Multiple B-lines are the sonographic
sign of lung interstitial syndrome, and their number
increases along with decreasing air content (see addi-
tional file 2). When the air content is further decreased,
such as in lung consolidations, the acoustic window on
the lung becomes completely open, and the lung may be
directly visualized as a solid parenchyma, as the liver or
the spleen (figure 1). Consolidations may be then mea-
sured and followed-up.
There are some anectodical reports on B-lines since the
eighties [3,4]. In 1994, Targetta firstly described the pre-
sence of B-lines in diseased lungs [5]. But it was Daniel
Lichtenstein, a French intensivist, who established for
the first time the 2 main structural correlates of B-lines,
comparing ultrasound findings with chest computed
tomography (CT) [6]. CT data showed that B-lines were
correlated to the thickening of subpleural interlobular
septa in pulmonary interstitial edema, and to the fibrotic
thickening in pulmonary fibrosis. The modern era of
lung ultrasound (LUS) was born. It is true indeed, that
LUS had already been employed since many years for
the evaluation of pleural effusion (PE), but the acknowl-
edgement of the information provided by artifacts repre-
sented a completely new approach. In 2004, Picano and
Jambrik, in our laboratory, brought LUS from the Inten-
sive Care Unit to the Cardiology Department, describing
the correlation between EVLW assessed by chest X-ray,
and the number of B-lines detected by LUS [7]. In the
following years, experimental [8,9], clinical [10-14], and
methodological [15] validation of B-lines have been
provided.
Methodology
LUS examination can be performed using any commer-
cially available 2-D scanner, with any transducer (phased-
array, linear-array, convex, microconvex). There is no
need for a second harmonic or Doppler imaging mode. Correspondence: gargani@ifc.cnr.it
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graphic platform, from fully equipped machines to pocket
size ones [15]. Patients can be in the near-supine, supine
or sitting position, as clinically indicated [16]. All the chest
can be easily scanned by ultrasound, just laying the probe
along the intercostal spaces. However, some specific meth-
ods have been proposed: ultrasound scanning of the ante-
rior and lateral chest may be obtained on the right and left
hemithorax, from the second to the fourth (on the right
side to the fifth) intercostal spaces, and from the paraster-
nal to the axillary line, as previously described [7,17]; (fig-
ure 2). Other approaches have been proposed, for instance
by Volpicelli et al. [10], with evaluation of 8 scanning sites,
4 on the right and 4 on the left hemithorax. When asses-
sing B-lines - the most informative LUS sign for the cardi-
ologist - the sum of B-lines found on each scanning site
yields a score, denoting the extent of extravascular fluid in
the lung. In each scanning site, B-lines may be counted
from zero to ten. Zero is defined as a complete absence of
B-lines in the investigated area; the full white screen in a
single scanning site is considered, when using a cardiac
probe, as corresponding to 10 B-lines (figure 3). Some-
times B-lines can be easily enumerated, especially if they
are a few; whereas, when they are more numerous, it is
less easy to clearly enumerate them, since they tend to be
confluent. In this situation, in order to obtain a semiquan-
tification of the sign, one can consider the percentage of
the scanning site occupied by B-lines (i.e. the percentage
of white screen compared to black screen) and then divide
it by ten (figure 3). For clinical purposes, B-lines may
be categorized from mild to severe degree, similar to
what is done for most echocardiographic parameters [16],
(table 1). B-lines have a very satisfactory intraobserver and
interobserver variability, around 5% and 7%, respectively [7].
Clinical applications
Heart failure
Diagnosis
In a 1994 review on the assessment of EVLW, Lange
stated that «The possibility to detect pulmonary edema
before it becomes clinically apparent, is so inherently
attractive that the effort to develop and validate such
technique still continues after many years of tireless and
relatively unrewarding attempts» [18]. Chest X-ray
remains by far the best and most used screening test for
the detection of pulmonary edema, but it is often diffi-
cult to interpret and imprecise, and with high interob-
server variability [19]. The absence of chest X-ray
findings does not exclude the presence of a high pul-
monary capillary wedge pressure (PCWP) [20]. Accord-
ing to recent 2009 AHA/ACC guidelines, serial chest X-
rays are not recommended in the assessment of pul-
monary congestion in chronic heart failure (HF), since
they are too insensitive to detect but the most extreme
Normal Mild/moderate Se ere Consolidation
“GREY”
Normal Mild/moderate
interstitial edema
Severe
interstitial edema/
alveolar edema
Consolidation
Air
100% 0%
Air
Figure 1 Physical basis of lung ultrasound.T h el e s sa i ri si nt h e
lung, the easier is the detection of lung abnormalities by
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Figure 2 Methodology for lung ultrasound evaluation.T h o r a c i c
scanning areas for semiquantitative assessment of B-lines. (Modified
from Jambrik et al, 2004 [7]).
No B-lines One B-line Two B-lines
Full white screen = 10 B-lines Three B-lines Five B-lines
Figure 3 How to enumerate B-lines. Each hyperechogenic vertical
stripe, spreading from the pleural line and extending to the edge of
the screen, is a B-line. When using a cardiac probe, a whole white
screen is considered as corresponding to a plateau value of 10
B-lines.
Table 1 Scoring of B-lines
Score Number of B-lines Extravascular lung water
0 ≤ 5 No sign
1 6 - 15 Mild degree
2 16 - 30 Moderate degree
3 > 30 Severe degree
(Modified from Picano et al, 2006 [16]).
Gargani Cardiovascular Ultrasound 2011, 9:6
http://www.cardiovascularultrasound.com/content/9/1/6
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PCWP via catheterization is the gold standard to evalu-
ate hemodynamic congestion, but its invasive nature
limits clinical utility. Thus, because the current technol-
ogy for measuring pulmonary edema can be inaccurate
(chest X-ray), cumbersome (nuclear medicine and radi-
ology techniques), or invasive (indicator dilution), there
is great potential for a technology that could quantify
pulmonary edema non-invasively in real time, with a
radiation-free and portable method.
B-lines have been proposed as a reliable ultrasound
technique for the assessment of pulmonary congestion
in HF patients. The number of B-lines increases with
worsening New York Heart Association (NYHA) func-
tional class [14]. Sonographic B-lines are related to
radiographic Kerley B-lines and lung water score on
chest X-ray [7], to EVLW measured invasively by the
thermodilution method [9], and to the severity of diasto-
lic dysfunction, for any given level of systolic dysfunc-
tion [14]. B-lines are useful for the differential diagnosis
of cardiogenic versus non-cardiogenic dyspnea. Lichten-
stein et al., firstly described that B-lines could differenti-
ate acute cardiogenic pulmonary edema from
exacerbation of chronic obstructive pulmonary disease
(COPD), since B-lines were present in all patients with
cardiogenic edema, whereas 24 of the 26 patients with
exacerbation of COPD had no B-lines, with a sensitivity
of 100% and a specificity of 92% [12]. These data were
further confirmed by our group, as we found that B-
lines are reliable in predicting the cardiogenic origin of
dyspnea, with an accuracy comparable to natriuretic
peptides [11]. B-lines could be a plausible alternative in
acute settings where natriuretic peptide analysis is not
available, or when there is no time enough to perform
it, as in patients with rapidly developing acute respira-
tory failure. Moreover, they could aid when natriuretic
peptides levels are in the “grey zone”.
B-lines are very dynamic, as shown by their rapid
increase after exercise, both in patients with and without
left ventricular dysfunction [22]. An “alveolar-capillary
stress echo” is possible by evaluation of B-lines changes
during stress. They can be easily added to wall motion
score index and valvular heart disease assessment during
stress echocardiography, providing the additional infor-
mation of the appearance of EVLW, not inferable by any
other echocardiographic parameter. The presence of B-
lines at peak stress can distinguish patients with stress-
induced high left ventricular filling pressures but without
failure of the alveolar-capillary membrane (hemodynamic
congestion), from patients with stress-induced high left
ventricular filling pressures and failure of the alveolar-
capillary membrane, that leads to redistribution of ﬂuid
within the lungs (pulmonary congestion) (figure 4).
In less than ten years, the proposal to use B-lines to
evaluate pulmonary congestion in HF patients, has
moved from the research setting to the clinical arena,
and it is now entering recommendation papers [23,24].
Recently, it has been endorsed by a scientific statement
by the Acute Heart Failure Committee of the Heart Fail-
ure Association of the European Society of Cardiology
as future direction for assessing and grading congestion
in acute HF [24].
In HF patients, LUS may also enable the detection of PE.
Evaluation of PE is the more established application of
LUS [1]. The effusion should firstly be sought in depen-
dent zones, i.e. lateral and posterior chest. In presence of a
radiopacity on chest X-ray, LUS is able to better differenti-
ate PE from atelectasis, consolidations, masses or an ele-
vated hemidiaphragm, and can be repeated serially at
bedside. LUS has a better sensitivity and reliability than
bedside chest X-ray for the diagnosis of PE [25]. Bedside
chest X-ray rarely detects small effusions and can also
miss effusions of up to 500 mL [26]. LUS may detect the
effusion, evaluate its extension, and indicate the appropri-
ate area for an eventual thoracentesis.
Treatment
The recognition, quantification and monitoring of pul-
monary congestion is important for the clinician at all
stages of care of the HF patient. Accurate assessment
of effectiveness of medical treatment is mandatory in
these patients [27]. Chest X-ray is the most used
screening test for in-hospital follow-up of pulmonary
congestion, although showing the above mentioned
limitations. Another way to monitor congestion is
through monitoring body weight. However, it has a
limited reliability as a predictor of congestion status, as
body weight fluctuations may not always reflect
changes in intravascular volume, and weight gain may
reflect normal fluctuations in time, and weight loss
Peak E/E’ Peak B-lines
normal
no congestion
elevated
hemodynamic
congestion
elevated
congestion
elevated
pulmonary
congestion
Figure 4 Alveolar-capillary membrane stress echo.T h e
additional value of B-lines evaluation during stress
echocardiography.
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obscure increased fluid retention [28].
B-lines have been proposed as a bedside, easy-to-use,
alternative diagnostic tool for clinically monitoring pul-
monary congestion in HF patients [13], as they clear
after adequate medical treatment. Since B-lines can be
dissolved in a few minutes by an acute diuretic load,
they may represent a useful bedside tool to monitor, in
a real-time fashion, diuretic therapy response [29]. The
dynamic behaviour of B-lines is highlighted also by their
significant reduction after dialysis [30]. B-lines resolu-
tion occurs real-time as fluid is removed from the body
[31], suggesting that this method could be easily
employed in all situations where a dynamic evaluation
of fluid changes is of importance.
The simplicity and low-techology of this examination
makes it appealing also for an out-hospital office moni-
toring of HF patients. Pharmacological therapy could be
tailored as soon as the patient, although asymptomatic,
shows a significant increase in B-lines number. This
could, at least in theory, prevent some new hospitaliza-
tions for worsening dyspnea, since symptoms would
appear with some days of delay [32]. The possibility to
assess B-lines with light, portable, hand-held devices,
could also allow the cardiologist to evaluate the degree
of decompensation at patients’ home [15].
Prognosis
Persistent hemodynamic congestion, that is not ade-
quately recognised and treated before discharge, is asso-
ciated with adverse clinical outcome in HF patients [27].
On the other hand, post-discharge freedom of pulmon-
ary congestion is associated with a better prognosis [33].
It has been demonstrated that in patients admitted to
the hospital with dyspnea and/or chest pain, the pre-
sence of B-lines identifies a subgroup at higher risk of
experiencing events: the higher the number of B-lines,
the worse the outcome. The 16-month event-free survi-
val showed a significantly better outcome for patients
without B-lines, whereas a worse outcome was observed
in patients with a severe degree of B-lines. In regard to
future HF hospitalizations alone, and not as part of the
combined end-point, the rate of new hospitalization for
progression of HF was also higher in patients with
severe B-lines and lower in patients without B-lines [34].
In patients with acute coronary syndromes, the number
of B-lines, associated to some very easy echocardiographic
parameters of left and right cardiac function, provide a
clear prognostic stratification in a composite end-point
including death, non-fatal myocardial infarction and new
admission for acute decompensated HF [35].
From a practical point of view, B-lines assessment may
be useful at all stages of HF management: in outpatients,
to monitor increasing EVLW as a sign of impending
decompensation, that is more reliable than body weight
changes; for the primary diagnosis of acute HF syn-
dromes, in patients admitted with acute dyspnea to the
Emergency Room, where even an old, low-technology
echographic device may allow B-lines detection; during
hospitalization for risk stratification and to titrate thera-
pies, and for prognostic stratification at discharge.
Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome (ARDS) is a com-
mon syndrome of diffuse lung injury with a high mortal-
ity rate [36]. Differential diagnosis between acute
cardiogenic pulmonary edema and ARDS may often be
difficult. In ARDS, LUS may provide a very early detec-
tion of pulmonary edema [8]. LUS showed a sensitivity
of 98% and a specificity of 88% in diagnosing the pre-
sence of the interstitial syndrome as seen at CT, per-
forming better than both auscultation and chest X-ray
[37]. Being a condition of pulmonary edema, although
non-cardiogenic, the sonographic pattern of multiple B-
lines is present in ARDS as well as in cardiogenic pul-
monary edema. However, there are some clues that may
help to differentiate the two conditions, since they are
often found in ARDS, but are not present in cardiogenic
pulmonary edema: alterations of the pleura, due to small
subpleural consolidations; “spared areas”, defined as
areas of normal sonographic lung appearance sur-
rounded by areas of multiple B-lines; large consolida-
tions of various size [38]. In patients with acute
dyspnea, multiple B-lines associated to pleural altera-
tions, represented by subpleural consolidations, are
highly suggestive of non-cardiogenic pulmonary edema
(Figure 5).
Although not frequently, the cardiologist may some-
times need to differentiate ARDS from cardiogenic pul-
monary edema, especially in Intensive Care Unit, in
Acute cardiogenic 
pulmonary edema
Chronic
heart failure
ALI/ARDS Pulmonary 
fibrosis
hi hi Clinical setting acute chronica c u t e c hronic
B-lines number ++++ +/++/+++ ++++ +/++/+++
B-lines
distribution
multiple, diffuse, 
bilateral
(white lung)
multiple, diffuse, 
bilateral, following 
decubitant regions
(black and white lung)
non-homogeneous
distribution, presence 
of spared areas
more frequently 
posterior at lung 
basis
Other LUS signs pleural effusion pleural effusion pleural effusion, pleural 
alterations,
parenchymal
consolidations of 
various size
pleural thickening
Echocardiogram abnormal abnormal likely normal likely normal
ALI = acute lung injury; ARDS = acute respiratory distress syndrome; LUS = lung ultrasound.
Figure 5 How to distinguish different etiologies of interstitial
syndrome by lung ultrasound.
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rays are often very difficult to interpret, whereas LUS is
much less affected from being performed at bedside.
Moreover, LUS may be of great help in resource-limited
settings, where an early diagnosis of ARDS can be life-
saving, as in high altitude pulmonary edema [39,40] and
after apnea diving [41].
In ARDS, LUS is useful not only in the diagnosis, but
also in the follow-up: bedside LUS is able to adequately
estimate lung recruitment induced by positive end-
expiratory pressure (PEEP) [42], with a high significant
correlation between CT and ultrasound lung reaeration
scores [43].
Pneumothorax
Pneumothorax (PTX) can occur after cardiothoracic sur-
gery. Bedside chest X-ray may misdiagnose up to 30% of
cases [44]. Radiographically “occult” PTX may rapidly
progress to tension PTX, if its diagnosis is missed or
delayed, especially in patients receiving mechanical ven-
tilation [45]. Cardiologists may be able to diagnose PTX
while performing an echocardiogram. Being a nonde-
pendent condition, in the supine patient PTX should be
sought at first at the least gravitationally dependent
areas, progressing more lateral. Absence of lung sliding
is a basic and initial step for the diagnosis [46]. Lung
sliding is the dynamic horizontal movement of the
pleural line, synchronized with respiration (see addi-
tional file 1). For objectifying and documenting normal
lung sliding, M-mode yields a simple pattern, the sea-
shore sign (Figure 6, panel A). The presence of lung slid-
ing allows PTX to be confidently discounted because the
negative predictive value is 100% [44]. The abolition of
lung sliding can be also evaluated by M-mode, which
shows a characteristic pattern, the stratosphere sign
(Figure 6, panel B), opposed to the normal seashore sign.
However, absent lung sliding does not always mean
PTX. Many other situations yield abolished lung sliding,
such as high-frequency ventilation, massive atelectasis,
pleural adherences, severe fibrosis, etc. Another condi-
tion needed for a LUS diagnosis of PTX is the absence
of B-lines: the slightest B-line allows prompt ruling out
of PTX [47]. However, the only pathognomonic LUS
s i g no fP N Xi st h elung point, that allows PTX to be
confirmed, with a specificity of 100%, and sensitivity of
about 65%. Lung point is the precise area of the chest
wall, where the regular reappearance of the lung sliding
replaces the PTX pattern. It corresponds to the point
where visceral and parietal pleura regain contact with
each other. M-mode performed at the lung point, shows
a clear change from one pattern to the other [48],
(Figure 6, panel C).
Acute coronary syndromes
In acute coronary syndromes, LUS should be considered
as an extension of the echocardiogram, allowing in a
few minutes the evaluation of pulmonary congestion,
that is often difficult to be assessed with low-quality
bedside chest X-rays. Evaluation of B-lines may also
p r o v i d ep r o g n o s t i cs t r a t i f i c a t i o n[ 3 5 ] ,a n dm a yi d e n t i f y
subjects at higher risk to develop acute pulmonary
edema.
Pulmonary fibrosis
Being a sign of thickened pulmonary interstitium, B-
lines may also be present in pulmonary fibrosis [49,50].
In patients with known pulmonary fibrosis or at high
risk to develop it - as in systemic sclerosis - B-lines may
be an additive tool for an early detection and semiquan-
tification of lung involvement. When aimed to evaluate
pulmonary fibrosis, LUS evaluation should be focused
not only on anterior and lateral chest, but also on pos-
terior chest, because fibrotic accumulation often starts
posteriorly at lung basis.
The 2 types of B-lines - cardiogenic/watery and pneu-
mogenic/fibrotic B-lines - can pose a challenge to differ-
ential diagnosis, although some parameters may help
distinguish the two entities: cardiogenic B-lines are
always bilateral and are generally more diffuse on the
right lung than on the left lung, with a “hot zone” of
higher density along the axillary lines (in lying patients,
as decubitant regions) [7], (Figure 5); moreover cardio-
genic B-lines can be dissolved in a few hours by an
a c u t ed i u r e t i cl o a d[ 1 3 ] .W i thin the clinical context of
acute dyspnea, B-lines changes associated with clinical
improvement, can be safely attributed to a reduction in
lung water content. Other LUS signs may also help to
differentiate the etiology of B-lines: in patients with con-
gestive HF, both in acute and chronic settings, no
A B C
Figure 6 A. Normal lung pattern on M-mode: the seashore sign.
The motionless superficial layers generate horizontal lines (the
waves). The deep artifacts follow the lung sliding, hence the sandy
pattern. B. Exclusively horizontal lines are displayed, indicating
complete absence of dynamics at the level of, and below, the
pleural line, a pattern called the stratosphere sign. C. M-mode
evaluation of the lung point: a sudden change from the seashore to
the stratosphere sign is clearly visible (arrow). (Modified from
Lichtenstein et al, 2000 [48]).
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pulmonary fibrosis B-lines are often associated to an evi-
dent thickening of the pleura (Figure 5).
Integrated cardio-pulmonary ultrasound
evaluation
Echocardiography is an essential tool for the cardiolo-
gist, providing a huge amount of information on both
acute and chronic situations. The addition of LUS to
echocardiography provides an additive insight on the
eventual pulmonary involvement. The cardiopulmonary
system is so interconnected, that an integrated approach
is mandatory. Presence of multiple, diffuse, bilateral B-
lines associated to left ventricular systolic and/or diasto-
lic dysfunction or valvular heart disease is highly indica-
tive of cardiogenic pulmonary congestion (Figure 5).
Moreover, for any given level of cardiac dysfunction, the
response of the pulmonary vascular bed may be variable:
LUS helps identifying those patients who, although
asymptomatic, are going to decompensate and require a
more aggressive treatment.
Presence of multiple, diffuse, bilateral B-lines, asso-
ciated to a normal heart, indicates a non-cardiac cause
of pulmonary edema, as acute lung injury (ALI)/ARDS,
interstitial pneumonia; alternatively, especially in a
chronic setting, it should pose the suspicion of pulmon-
ary fibrosis (Figure 5). It is important to distinguish the
multiple, diffuse, bilateral B-lines pattern from focal
multiple B-lines, that can be present in normal lungs or
may be seen around many pathologic conditions, as
lobar pneumonia, pulmonary contusion, pulmonary
infarction, pleural disease, neoplasia. This further under-
lines the importance to integrate LUS findings with
patients’ history, clinical presentation and other instru-
mental data. An overview of the main clinical applica-
tions of LUS for the cardiologist is shown in Figure 7.
LUS is one of the easiest application of echography,
much easier than echocardiography. Images patterns are
readily teachable, and minimal didactic and image
recognition skill sessions are needed [51]. The learning
curve for B-lines evaluation and grading is very short
[15]. The complement of LUS to echocardiography
would require only a few minutes in addition to the
time needed for a resting echocardiogram.
Limitations
LUS limitations are essentially patient dependent. Obese
patients are frequently difficult to examine because of
the thickness of their ribcage and soft tissues. The pre-
sence of subcutaneous emphysema or large thoracic
dressings alters or precludes the propagation of ultra-
sound beams to the lung periphery.
The main limitation of B-lines is the lack of specificity.
As already mentioned, they are a sign of interstitial
syndrome, therefore they are a very sensitive but not
specific sign of cardiogenic pulmonary edema. How to
distinguish the different etiologies of B-lines has been
discussed. However, it must be always reminded that all
instrumental data should be evaluated within the clinical
context and integrated with patient’sh i s t o r y .N os i n g l e
test alone allows to establish the diagnosis.
Conclusions
Providing a reliable, simple and repeatable estimation of
EVLW, B-lines assessment by LUS represents a new,
helpful tool for the cardiologist, to be employed at all
stages of the management of HF patients, and for the
differential diagnosis of dyspnea. LUS can further help
in the diagnosis of other pulmonary conditions, that
may be challenging in a Cardiology or Cardiac Surgery
Department. Adding LUS to echocardiography may help
to differentiate the main causes of acute dyspnea.
Additional material
Additional file 1: Sonographic pattern of the normal lung: the
horizontal hyperechoic line moving synchronously with respiration
is the pleura.
Additional file 2: Sonographic pattern of interstitial syndrome:
multiple B-lines originate from the pleural line.
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Clinical applications References Level of 
evidence
Acute dyspnea Differential diagnosis of 
cardiogenic vs non cardiogenic
11, 12
cardiogenic vs non-cardiogenic
dyspnea
Chronic
heart failure
Assessing and grading 
congestion
6, 7, 9, 10, 22, 24
Tailor therapy 13
ALI/ARDS - Early diagnosis
- Differential diagnosis with
8
38 Differential diagnosis with
cardiogenic pulmonary edema 
- Lung recruitment evaluation
38
42, 43
HAPE Pre-clinical detection 40, 41
Dialysis Lung fluid dynamic evaluation 30, 31
Acute coronary Prognostic stratification 34 35 Acute coronary
syndromes
Prognostic stratification 34, 35
Stress-echo Identification of alveolar-
capillary membrane stress 
failure as sign of overt heart
22
failure, as sign of overt heart
failure
ALI = acute lung injury; ARDS = acute respiratory distress syndrome; HAPE = high altitude pulmonary edema.
Green star = recommendation papers, statements by scientific communities
Yellow star = original papers on ISI journals
Figure 7 Overview of the main clinical applications of lung
ultrasound for the cardiologist.
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